PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $758K invested in Purple Biotech in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$215K
2
+$66K
3
+$57K
4
UBS Group
UBS Group
Switzerland
+$5K
5
MIFH
Migdal Insurance & Financial Holdings
Israel
+$1K

Top Sellers

1
-$115K
2
-$49K
3
-$17.4K
4
Wells Fargo
Wells Fargo
California
-$7K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$257K
2
$239K
3
$175K
4
$57K
5
$24K
6
$5K
7
$1K
8
–
9
–
10
–
11
–
12
–